CAM

Cormorant Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,000	Closed	-$400K	–	116
2021 Q1	$400K	Sell	20,000 -20,000	-50%	-$400K	0.01%	114
2020 Q4	$680K	Sell	40,000 -10,000	-20%	-$170K	0.02%	97
2020 Q3	$830K	Sell	50,000 -75,000	-60%	-$1.25M	0.03%	84
2020 Q2	$2.9M	Sell	125,000 -25,000	-17%	-$579K	0.11%	70
2020 Q1	$2.68M	Sell	150,000 -50,000	-25%	-$893K	0.12%	61
2019 Q4	$4.32M	Sell	200,000 -588,800	-75%	-$12.7M	0.17%	57
2019 Q3	$14.4M	Buy	788,800 +388,800	+97%	+$7.08M	0.87%	31
2019 Q2	$14.2M	Sell	400,000 -100,000	-20%	-$3.56M	0.82%	35
2019 Q1	$16.8M	Sell	500,000 -47,000	-9%	-$1.58M	1.14%	29
2018 Q4	$18M	Sell	547,000 -823,000	-60%	-$27.1M	1.46%	24
2018 Q3	$83.5M	Sell	1,370,000 -130,000	-9%	-$7.92M	5.43%	3
2018 Q2	$73.2M	Sell	1,500,000 -1,063,200	-41%	-$51.9M	5.42%	4
2018 Q1	$272M	Buy	2,563,200 +565,500	+28%	+$60.1M	20.3%	1
2017 Q4	$119M	Buy	+1,997,700	New	+$119M	12.49%	2
2016 Q3	–	Sell	-2,022,879	Closed	-$28.8M	–	88
2016 Q2	$28.8M	Buy	2,022,879 +22,879	+1%	+$326K	4.08%	5
2016 Q1	$27.5M	Buy	2,000,000 +1,234,844	+161%	+$17M	4.14%	5
2015 Q4	$12.9M	Buy	765,156 +367,656	+92%	+$6.2M	1.54%	24
2015 Q3	$4.36M	Hold	397,500	–	–	0.7%	41
2015 Q2	$4.97M	Hold	397,500	–	–	0.66%	42
2015 Q1	$4.37M	Sell	397,500 -52,500	-12%	-$578K	0.68%	43
2014 Q4	$6.98M	Hold	450,000	–	–	1.08%	28
2014 Q3	$5.43M	Buy	+450,000	New	+$5.43M	1.12%	26